Impact of Mail-based Intervention on Adherence to Direct Oral Anticoagulants Among Medicare and Medicaid Beneficiaries

October 20, 2025

Medication nonadherence affects nearly half of patients receiving chronic therapies and continues to be a significant driver of poor outcomes and rising health care costs. Although direct oral anticoagulants (DOACs) offer established clinical benefits, less frequent monitoring can make it harder for some patients to stay on therapy over time. Mail-based interventions may provide insight into strategies that improve adherence among Medicare and Medicaid beneficiaries and support better long-term outcomes.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

CLARITY FOR ACTION

Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download

Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.

Related blogs

Navigating Healthcare and Improving Outcomes